| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3411ff2717c473526972a7882b1fb120 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
| filingDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b8c0da103b9252d6c7ad37f84a0821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4230843b71d22b4d306274cfb9640b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_044a7a5bf7edd693e6b08b2a0c630f8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e253edfdb899c70b0ef139d644fec650 |
| publicationDate |
2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021113489-A1 |
| titleOfInvention |
Pharmaceutical composition and method for treating seizure disorders |
| abstract |
The present disclosure relates to the transdermal administration of cannabidiol (CBD) for the reduction of seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113698802-A |
| priorityDate |
2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |